These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 38130204)

  • 1. Biologics for Hidradenitis suppurativa: evolution of the treatment paradigm.
    Maronese CA; Moltrasio C; Genovese G; Marzano AV
    Expert Rev Clin Immunol; 2024 May; 20(5):525-545. PubMed ID: 38130204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hidradenitis suppurativa: new insights into disease mechanisms and an evolving treatment landscape.
    Krueger JG; Frew J; Jemec GBE; Kimball AB; Kirby B; Bechara FG; Navrazhina K; Prens E; Reich K; Cullen E; Wolk K
    Br J Dermatol; 2024 Jan; 190(2):149-162. PubMed ID: 37715694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Implementation of Biologics and Small Molecules in the Treatment of Hidradenitis Suppurativa.
    Aarts P; Dudink K; Vossen ARJV; van Straalen KR; Ardon CB; Prens EP; van der Zee HH
    Drugs; 2021 Aug; 81(12):1397-1410. PubMed ID: 34283386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in biologic and small molecule therapies for hidradenitis suppurativa.
    Chen SX; Greif C; Gibson RS; Porter ML; Kimball AB
    Expert Opin Pharmacother; 2022 Jun; 23(8):959-978. PubMed ID: 35470765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Narrative Review and Update on Biologic and Small Molecule Drugs for Hidradenitis Suppurativa: An Entity With a Promising Future.
    Mansilla-Polo M; Escutia-Muñoz B; Botella-Estrada R
    Actas Dermosifiliogr; 2023 Oct; 114(9):T772-T783. PubMed ID: 37541580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Narrative Review and Update on Biologic and Small Molecule Drugs for Hidradenitis Suppurativa: An Entity With a Promising Future.
    Mansilla-Polo M; Escutia-Muñoz B; Botella-Estrada R
    Actas Dermosifiliogr; 2023 Oct; 114(9):772-783. PubMed ID: 37211274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
    Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J
    Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A safety review of biologic therapies for the management of hidradenitis suppurativa and unmet needs.
    Holcomb ZE; Porter ML; Kimball AB
    Expert Opin Drug Saf; 2021 Oct; 20(10):1147-1161. PubMed ID: 33910441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of biologics and JAK inhibitors in the management of moderate to severe Hidradenitis Suppurativa treatment: a scoping review.
    Guermazi D; Shah A; Yumeen S; Saliba E
    Arch Dermatol Res; 2024 May; 316(6):259. PubMed ID: 38795234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological development in hidradenitis suppurativa.
    Matusiak Ł; Jemec GB; Szepietowski JC
    Curr Opin Pharmacol; 2019 Jun; 46():65-72. PubMed ID: 31075754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic, pharmacokinetic, and toxicological issues of biologic therapies currently used in the treatment of hidradenitis suppurativa.
    Molinelli E; Sapigni C; Campanati A; Brisigotti V; Offidani A
    Expert Opin Drug Metab Toxicol; 2020 Nov; 16(11):1019-1037. PubMed ID: 32896186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologic Treatment for Hidradenitis Suppurativa.
    Flood KS; Porter ML; Kimball AB
    Am J Clin Dermatol; 2019 Oct; 20(5):625-638. PubMed ID: 31140067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anti-inflammatory potency of biologics targeting tumour necrosis factor-α, interleukin (IL)-17A, IL-12/23 and CD20 in hidradenitis suppurativa: an ex vivo study.
    Vossen ARJV; Ardon CB; van der Zee HH; Lubberts E; Prens EP
    Br J Dermatol; 2019 Aug; 181(2):314-323. PubMed ID: 30657173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of Characteristics and Trends in Treatment Response of Hidradenitis Suppurativa Patients: A Southern US Cohort Study.
    Peterson GC; Preston A; Frieder J; Wang X; Paek SY
    Dermatology; 2020; 236(5):413-420. PubMed ID: 31935718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secukinumab in the treatment of hidradenitis suppurativa.
    Snyder CL; Gibson RS; Porter ML; Kimball AB
    Immunotherapy; 2023 Dec; 15(17):1449-1457. PubMed ID: 37840286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biology of Interleukin-17 and Novel Therapies for Hidradenitis Suppurativa.
    Sabat R; Gudjonsson JE; Brembilla NC; van Straalen KR; Wolk K
    J Interferon Cytokine Res; 2023 Dec; 43(12):544-556. PubMed ID: 37824200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Target molecules for future hidradenitis suppurativa treatment.
    Zouboulis CC; Frew JW; Giamarellos-Bourboulis EJ; Jemec GBE; Del Marmol V; Marzano AV; Nikolakis G; Sayed CJ; Tzellos T; Wolk K; Prens EP
    Exp Dermatol; 2021 Jun; 30 Suppl 1():8-17. PubMed ID: 34085329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effectiveness of Guselkumab in Patients With Hidradenitis Suppurativa Under Clinical Practice Conditions: A Spanish Multicentre Retrospective Study.
    Rivera-Díaz R; Pozo T; Alfageme F; Díaz Ley B; Osorio GF; Chico R; Vilarrasa E; Silvente C; Ciudad Blanco C; Romaní J; Martorell A; Fernández P; Romero Ferreiro C; Molina Leyva A
    Actas Dermosifiliogr; 2023 Oct; 114(9):T755-T762. PubMed ID: 37479135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New and Emerging Targeted Therapies for Hidradenitis Suppurativa.
    Markota Čagalj A; Marinović B; Bukvić Mokos Z
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adalimumab for the treatment of hidradenitis suppurativa/acne inversa.
    Zouboulis CC
    Expert Rev Clin Immunol; 2016 Oct; 12(10):1015-26. PubMed ID: 27531618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.